Literature DB >> 24132847

Effects of exercise on mobility in people with Parkinson's disease.

Nicolien M van der Kolk1, Laurie A King.   

Abstract

Parkinson's disease is a prevalent neurodegenerative disorder for which only symptomatic treatment exists. Gait and balance disturbance is common in Parkinson's disease and is a major contributor to increased disability and decreased health-related quality of life and survival. Balance and gait deficits in Parkinson's disease are notoriously difficult to treat and are not significantly helped by pharmacological or surgical treatment. The last two decades have seen a dramatic increase in the research and clinical interest in using exercise as a treatment for mobility problems in people with Parkinson's disease. With exciting advances in basic science research suggesting neurochemical and neuroplastic changes after exercise, an increasing number of high-quality studies are documenting particular aspects of mobility improving after exercise. Exercise has the potential to help both motor (gait, balance, strength) and nonmotor (depression, apathy, fatigue, constipation) aspects of Parkinson's disease as well as secondary complications of immobility (cardiovascular, osteoporosis). This perspective article focuses primarily on recent evidence on the effects of exercise in improving mobility while highlighting the importance of targeted exercise intervention for maximizing the benefits of exercise. Suggestions for exercise guidelines, adherence issues, and directions for future research are provided.
© 2013 Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; exercise; mobility; physical therapy

Mesh:

Year:  2013        PMID: 24132847     DOI: 10.1002/mds.25658

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  37 in total

Review 1.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

Review 2.  Classification of gait disturbances: distinguishing between continuous and episodic changes.

Authors:  Nir Giladi; Fay B Horak; Jeffrey M Hausdorff
Journal:  Mov Disord       Date:  2013-09-15       Impact factor: 10.338

Review 3.  DCTN1-related neurodegeneration: Perry syndrome and beyond.

Authors:  Takuya Konno; Owen A Ross; Hélio A G Teive; Jarosław Sławek; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2017-06-12       Impact factor: 4.891

4.  Neurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus Monkeys.

Authors:  Jeanette M Shultz; Henry Resnikoff; Viktorya Bondarenko; Valerie Joers; Andres Mejia; Heather Simmons; Marina E Emborg
Journal:  J Alzheimers Dis Parkinsonism       Date:  2016-11-03

5.  Recruitment of the prefrontal cortex and cerebellum in Parkinsonian rats following skilled aerobic exercise.

Authors:  Zhuo Wang; Yumei Guo; Kalisa G Myers; Ryan Heintz; Daniel P Holschneider
Journal:  Neurobiol Dis       Date:  2015-03-03       Impact factor: 5.996

6.  Investigation of factors impacting mobility and gait in Parkinson disease.

Authors:  Gustavo Christofoletti; Marie E McNeely; Meghan C Campbell; Ryan P Duncan; Gammon M Earhart
Journal:  Hum Mov Sci       Date:  2016-08-20       Impact factor: 2.161

7.  Effects of Group, Individual, and Home Exercise in Persons With Parkinson Disease: A Randomized Clinical Trial.

Authors:  Laurie A King; Jennifer Wilhelm; Yiyi Chen; Ron Blehm; John Nutt; Zunqiu Chen; Andrea Serdar; Fay B Horak
Journal:  J Neurol Phys Ther       Date:  2015-10       Impact factor: 3.649

8.  Effects of Global Postural Reeducation on gait kinematics in parkinsonian patients: a pilot randomized three-dimensional motion analysis study.

Authors:  Valeria Agosti; Carmine Vitale; Dario Avella; Rosaria Rucco; Gabriella Santangelo; Pierpaolo Sorrentino; Pasquale Varriale; Giuseppe Sorrentino
Journal:  Neurol Sci       Date:  2015-12-23       Impact factor: 3.307

Review 9.  Treatment of advanced Parkinson's disease.

Authors:  Juan C Giugni; Michael S Okun
Journal:  Curr Opin Neurol       Date:  2014-08       Impact factor: 5.710

Review 10.  Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.

Authors:  Song Li; Jie Dong; Cheng Cheng; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2016-08-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.